HONG KONG – Hong Kong-based gene therapy company Reflection Biotechnologies Ltd. received orphan drug designation from the U.S. FDA for its gene therapy, RBIO-101, to treat Bietti's crystalline ...
HONG KONG & NEW YORK--(BUSINESS WIRE)--Reflection Biotechnologies Limited ("ReflectionBio"), a gene therapy company committed to the research and development of life-changing treatments for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results